Compare ATYR & AUDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATYR | AUDC |
|---|---|---|
| Founded | 2005 | 1992 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Telecommunications Equipment |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.2M | 267.0M |
| IPO Year | 2015 | 1999 |
| Metric | ATYR | AUDC |
|---|---|---|
| Price | $0.74 | $8.93 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 3 |
| Target Price | $8.75 | ★ $11.67 |
| AVG Volume (30 Days) | ★ 2.1M | 107.5K |
| Earning Date | 11-06-2025 | 02-03-2026 |
| Dividend Yield | N/A | ★ 4.51% |
| EPS Growth | N/A | ★ 15.76 |
| EPS | N/A | ★ 0.46 |
| Revenue | $190,000.00 | ★ $244,553,000.00 |
| Revenue This Year | N/A | $2.52 |
| Revenue Next Year | $18,728.88 | $3.15 |
| P/E Ratio | ★ N/A | $19.08 |
| Revenue Growth | N/A | ★ 0.15 |
| 52 Week Low | $0.64 | $8.01 |
| 52 Week High | $7.29 | $12.72 |
| Indicator | ATYR | AUDC |
|---|---|---|
| Relative Strength Index (RSI) | 43.06 | 48.60 |
| Support Level | $0.69 | $8.79 |
| Resistance Level | $0.76 | $9.20 |
| Average True Range (ATR) | 0.04 | 0.24 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 29.82 | 48.10 |
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
AudioCodes Ltd develops and sells onverged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.